Skip to content

Prophylaxis of Postoperative Nausea and Vomiting After Cardiac Surgery

Prophylaxis of Postoperative Nausea and Vomiting After Cardiac Surgery (PONVACS)

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02744495
Acronym
PONVACS
Enrollment
502
Registered
2016-04-20
Start date
2016-02-29
Completion date
2016-12-31
Last updated
2016-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Vomiting, Postoperative Nausea, Postoperative Emesis

Keywords

cardiac surgery, corticoids, droperidol, antiemetics, Postoperative Vomiting, Postoperative Nausea, Postoperative Emesis, prophylaxis

Brief summary

To investigate the role of postoperative nausea and vomiting risk factors assessment after cardiac surgery. We designed a randomized controlled study comparing standard care (no risk factor assessment and no intervention) with prophylaxis of postoperative nausea and vomiting after cardiac surgery in high risk patients. Prophylaxis of postoperative nausea and vomiting by betamethasone (4mg) and/or droperidol (0.625mg) immediately after cardiac surgery, depending on risk factors (if risk score is over 2) in the intervention arm.

Detailed description

Patients planned to undergo cardiac surgery were screened for inclusion. Inclusion criteria are as follow: Non emergent cardiac surgery; Age \> 18 years; Affiliation to French Social Security; Approval of participation to the study; at the exclusion of: Pregnancy ; Contra indication to antiemetics; Chronic usage of antiemetics; and Emergent or complicated surgery. Risk factors for postoperative nausea and vomiting were collected and patients were randomized by cluster into two arms. Control: No prophylaxis whatever risk score is. Postoperative nausea and vomiting risk factors were not available for practicians. Intervention: Preoperative collection of postoperative nausea and vomiting risk factors available for practicians. Prophylaxis if risk score is over 2. Prophylaxis of postoperative nausea and vomiting by betamethasone (4mg) and/or droperidol (0.625mg) immediately after cardiac surgery, depending on risk factors in the intervention arm. All outcomes are assessed at 48 hours of surgery: Primary: occurrence of postoperative nausea or vomiting Secondary: number of postoperative nausea and vomiting with visual assessment scale (VAS), and antiemetics used for treatment; postoperative pain (VAS) with number of analgesics used; postoperative discomfort (VAS). Safety data: side effects and QT corrected intervals.

Interventions

DRUGBetamethasone

Prophylaxis if risk score is over 2. Prophylaxis of postoperative nausea and vomiting by betamethasone / Celestene (4mg) and/or droperidol / Droleptan (0.625mg) immediately after cardiac surgery, depending on risk factors in the intervention arm.

Prophylaxis if risk score is over 2. Prophylaxis of postoperative nausea and vomiting by betamethasone / Celestene (4mg) and/or droperidol / Droleptan (0.625mg) immediately after cardiac surgery, depending on risk factors in the intervention arm.

Sponsors

Hôpital Privé de Parly II - Le Chesnay
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Non emergent cardiac surgery * Age \> 18 years * Affiliation to French Social Security * Approval of participation to the study

Exclusion criteria

* Pregnancy * Contra indication to antiemetics * Chronic usage of antiemetics * Emergent or complicated surgery

Design outcomes

Primary

MeasureTime frameDescription
postoperative nausea and vomiting48hourpostoperative nausea and vomiting as a categorical variable

Secondary

MeasureTime frameDescription
postoperative nausea and vomiting (VAS)48hourSuffering from postoperative nausea and vomiting by visual assessment scale (VAS). VAS is a 100 point scale: 0 indicate absence of nausea or vomiting; 100 indicate maximal nausea and vomiting
postoperative pain (VAS)48hourVAS is a 100 point scale: 0 indicate absence of pain; 100 indicate maximal pain
postoperative discomfort (VAS)48hourVAS is a 100 point scale: 0 indicate absence of discomfort; 100 indicate maximal discomfort
number of postoperative nausea and vomiting48hour
Analgesics48hourNumber of Analgesics used at 48h
Side effects48hour
QTc interval48hourPre and postoperative QTc (corrected) intervals
Antiemetics (treatment)48hourNumber of antiemetics used as a treatment for postoperative nausea or vomiting

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026